Sunitinib phase II study in patients with renal cell cancer

A commentary

Research output: Contribution to journalArticle

Original languageEnglish
JournalAmerican Journal of Hematology/ Oncology
Volume6
Issue number1
StatePublished - Jan 2007

Fingerprint

Renal Cell Carcinoma
sunitinib

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)

Cite this

@article{0bc5b081603d4025bc5dcfbf713d4e94,
title = "Sunitinib phase II study in patients with renal cell cancer: A commentary",
author = "Theodore Logan",
year = "2007",
month = "1",
language = "English",
volume = "6",
journal = "American Journal of Hematology/ Oncology",
issn = "1542-9520",
publisher = "TyWin Communications",
number = "1",

}

TY - JOUR

T1 - Sunitinib phase II study in patients with renal cell cancer

T2 - A commentary

AU - Logan, Theodore

PY - 2007/1

Y1 - 2007/1

UR - http://www.scopus.com/inward/record.url?scp=33846656963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846656963&partnerID=8YFLogxK

M3 - Article

VL - 6

JO - American Journal of Hematology/ Oncology

JF - American Journal of Hematology/ Oncology

SN - 1542-9520

IS - 1

ER -